黑料官网

header-logo
GettyImages-609179959-hero
headshot

Paul Hanna, MD, MSc, FASN

Director of Onconephrology, Assistant Professor

view physician profile

Locations

  • Froedtert Hospital
  • Nephrology - Center for Advanced Care - Froedtert Hospital

Specialties

  • Nephrology

Languages

  • English, Arabic

New & Established Patients Call

Education

  • MD - Doctor of Medicine
  • MSc - Master of Science
  • FASN - Fellow of the American Society of Nephrology

Clinical Expertise

  • Acute Kidney Injury
  • Atypical Hemolytic Uremic Syndrome
  • Chronic Kidney Disease-Mineral and Bone Disorder
  • Essential Hypertension
  • Glomerulonephritis
  • Hydronephrosis
  • Hyperparathyroidism, Secondary
  • Hypertension
  • Hypertension, Renal
  • Hypertension, Renovascular
  • Kidney Diseases
  • Kidney Failure, Chronic

Publications

  • (Sarmad A, Gholizadeh Ghozloujeh Z, Hanna PE, Kronbichler A, Geetha D, Heidari-Bateni G, Mathew R, Ahmad M, Mohammed A, Siddiqui S, Abdipour A, Norouzi S.) Nephrol Dial Transplant. 2025 Nov 26;40(12):2256-2267 PMID: 40280728 SCOPUS ID: 2-s2.0-105022928511 04/26/2025

  • (Kelly A, Sharma S, Mamlouk O, Hassanein M, Chowdhury R, Gupta S, Troung H, Bonilla M, Kalra K, Wanchoo R, Pariswala T, Turcotte AE, Zaveri I, Dernell C, Ibrahim M, Patel M, Eskander SS, Gudsoorkar P, Jhaveri KD, Perazella MA, Hanna PE.) Nephrol Dial Transplant. 2025 Nov 17 PMID: 41247096 11/17/2025

  • (Lyu J, Specht K, Seiglie JA, Ouyang T, Mistry K, Seethapathy H, Zubiri L, Khor SY, Hanna PE, Cao A, Moreno D, Mejia SM, Gupta S, Sise ME.) Cancer Lett. 2025 Nov 01;632:217958 PMID: 40738413 SCOPUS ID: 2-s2.0-105012130094 07/31/2025

  • (Kelly A, Sharma S, Mamlouk O, Hassanein M, Chowdhury R, Gupta S, Truong H, Bonilla M, Kalra K, Wanchoo R, Pariswala T, Turcotte AE, Zaveri I, Dernell C, Ibrahim M, Patel M, Eskander SS, Gudsoorkar P, Jhaveri KD, Perazella MA, Hanna PE.) Nephrol Dial Transplant. 2025 Oct 17 PMID: 41105138 10/17/2025

  • (Moreno D, Hanna PE, Mistry K, Heidari P, Sise ME, Seethapathy H.) Kidney Med. 2025 Aug;7(8):101038 PMID: 40740732 PMCID: PMC12304893 07/31/2025

  • (Lyu J, Mantz L, Katz-Agranov NS, Ouyang T, Hanna PE, Mejia SM, Moreno D, Lee M, Cao A, Dinulos JE, Cosar D, Shaker M, Shah SJ, Gainor JF, Temel JS, Lei M, Inker LA, Fintelmann FJ, Sise ME.) J Natl Compr Canc Netw. 2025 Jul 30;23(9):393-400 PMID: 40738140 SCOPUS ID: 2-s2.0-105015792212 07/31/2025

  • (Eilis Eschweiler, Anna Gaddy, and Paul E. Hanna.) Journal of Onconephrology. 12/17/2025

  • (Vinay Srinivasan, Ellen Cody, Margaret DeOliveira, and Paul E Hanna .) Journal of Onconephrology. 12/02/2025

  • (Vakhshoori M, Hanna PE, Obaidi Z, Chen Wongworawat Y, Abdipour A, Norouzi S.) J Investig Med High Impact Case Rep. 2025;13:23247096251323066 PMID: 40069965 PMCID: PMC11898078 03/12/2025

  • (Marta Pirovano, Paul E. Hanna, Mohamed Hassanein, Shruti Gupta .) StatPearls. 01/17/2025

  • (Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S.) Kidney Int Rep. 2024 Jun;9(6):1897-1902 PMID: 38899179 PMCID: PMC11184235 06/20/2024

  • (Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S.) Kidney International Reports. June 2024;9(6):1897-1902 SCOPUS ID: 2-s2.0-85189238641 06/01/2024

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.